C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China · Delayed Price · Currency is CNY 5.92
+0.05 (0.85%)
May 8, 2026, 3:04 PM CST
SHE:000950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 566.82 | 521.33 | 282.99 | 624.63 | 952.28 | 1,005 |
Depreciation & Amortization | 476.18 | 476.18 | 448.8 | 396.81 | 403.9 | 312.62 |
Other Amortization | 58.56 | 58.56 | 93.72 | 48.52 | 33.17 | 37.51 |
Loss (Gain) From Sale of Assets | -4.63 | -4.63 | -10.53 | -0.79 | -10.05 | -3.52 |
Asset Writedown & Restructuring Costs | 126.05 | 126.05 | 40.21 | 20.49 | 27.93 | 10.67 |
Loss (Gain) From Sale of Investments | -415.48 | -415.48 | -409.33 | -317.71 | -305.8 | -429.57 |
Provision & Write-off of Bad Debts | - | - | 531.72 | 388.33 | 124.48 | 282.22 |
Other Operating Activities | 347.28 | 1,544 | 1,299 | 1,505 | 1,336 | 1,053 |
Change in Accounts Receivable | -2,800 | -2,800 | -1,663 | -5,316 | -3,878 | -3,989 |
Change in Inventory | -149.15 | -149.15 | -1,432 | -752.22 | -1,824 | -185.46 |
Change in Accounts Payable | 1,673 | 1,673 | 728.6 | 4,007 | 3,401 | 2,183 |
Operating Cash Flow | -396.97 | 754.67 | -186.74 | 508.53 | 285.83 | 250.16 |
Operating Cash Flow Growth | - | - | - | 77.92% | 14.26% | -60.42% |
Capital Expenditures | -319.03 | -299.54 | -250.53 | -244.41 | -268.07 | -489.55 |
Sale of Property, Plant & Equipment | 1.07 | 1.01 | 1.4 | 0.83 | 6.59 | 11.65 |
Cash Acquisitions | -3.22 | -25.2 | -109.33 | -187.75 | -226.86 | -650.59 |
Divestitures | - | 0.4 | - | -28.9 | 81.85 | 33.3 |
Investment in Securities | 339.42 | 339.42 | 41.04 | 68.49 | 168.16 | -39.84 |
Other Investing Activities | 165.24 | 147.66 | 85.54 | 24.94 | 47.09 | 165.52 |
Investing Cash Flow | 183.48 | 163.75 | -182.46 | -358.38 | -191.24 | -969.51 |
Long-Term Debt Issued | - | 24,753 | 24,230 | 25,555 | 24,481 | 28,019 |
Long-Term Debt Repaid | - | -24,114 | -23,652 | -26,513 | -21,746 | -24,862 |
Net Debt Issued (Repaid) | 2,979 | 638.76 | 578.14 | -958.02 | 2,735 | 3,157 |
Issuance of Common Stock | - | - | - | - | - | 41.9 |
Common Dividends Paid | -853.62 | -873.57 | -1,120 | -1,299 | -928.81 | -1,227 |
Other Financing Activities | -746.06 | -719.63 | 590.28 | 2,510 | -626.11 | -429.17 |
Financing Cash Flow | 1,379 | -954.43 | 48.33 | 252.49 | 1,180 | 1,542 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.12 |
Net Cash Flow | 1,166 | -36.02 | -320.87 | 402.64 | 1,274 | 822.74 |
Free Cash Flow | -716 | 455.13 | -437.27 | 264.13 | 17.76 | -239.38 |
Free Cash Flow Growth | - | - | - | 1386.93% | - | - |
Free Cash Flow Margin | -0.87% | 0.55% | -0.54% | 0.34% | 0.03% | -0.38% |
Free Cash Flow Per Share | -0.41 | 0.26 | -0.25 | 0.15 | 0.01 | -0.14 |
Cash Income Tax Paid | 1,707 | 1,550 | 1,438 | 1,755 | 1,384 | 1,351 |
Levered Free Cash Flow | -2,185 | 271.76 | -1,389 | 1,225 | -2,481 | -3,830 |
Unlevered Free Cash Flow | -2,185 | 271.76 | -677.52 | 2,063 | -1,778 | -3,139 |
Change in Working Capital | -1,552 | -1,552 | -2,463 | -2,157 | -2,276 | -2,018 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.